Drug Formularies

Article

Leveraging biosimilars to drive savings and support patient access

By the end of 2024, 3 FDA-approved biosimilars to Stelara for patients living with inflammatory conditions will be closer to launch, enabling lower total drug spend.

July 01, 24

Article

The importance of a clinical-first approach to formulary development

The clinical efficacy of a drug must always take priority over any other considerations when developing formularies.

Andy Behm, PharmD, BCGP, February 05, 24

Article

Here’s what drug makers don’t want you to know about PBMs

Pharmacy benefit managers shield patients from higher drug prices, but drug makers don’t want you to know that.

September 13, 23

Article

With the right formulary, plans can control drug costs while preserving access

August 02, 2023

Each plan determines which formulary is best for its unique circumstances.

Article

Key considerations to support a robust biosimilar marketplace

July 24, 2023

We are taking a thoughtful and comprehensive approach to assessing biosimilar options that considers several factors.

Article

Meet Mark Bini, Head of Growth and Coordinated Care for Evernorth Care Solutions

Mark Bini's love for numbers comes in handy in his role as the Head of Growth and Coordinated Care for Evernorth Care Solutions. Learn more about how Mark and his team take a data-driven approach to i...

March 20, 23